Challenges of calculating cost-effectiveness thresholds
Lancet Glob Health
.
2023 Oct;11(10):e1508.
doi: 10.1016/S2214-109X(23)00351-0.
Authors
Laura Vallejo-Torres
1
,
Karl Claxton
2
,
Laura C Edney
3
,
Jonathan Karnon
3
,
James Lomas
2
,
Jessica Ochalek
2
,
Mike Paulden
4
,
Niek Stadhouders
5
,
David J Vanness
6
Affiliations
1
University of Las Palmas de Gran Canaria, Canary Islands 35017, Spain. Electronic address: laura.vallejo@ulpgc.es.
2
University of York, York, UK.
3
Flinders University, Adelaide, SA, Australia.
4
University of Alberta, Edmonton, AB, Canada.
5
Radboudumc IQ Healthcare, Nijmegen, Netherlands.
6
Pennsylvania State University Department of Health Policy and Administration, University Park, PA, USA.
PMID:
37734789
DOI:
10.1016/S2214-109X(23)00351-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Cost-Benefit Analysis*
Humans